Livongo Health Inc (OQ:LVGO)

Business Focus: Medical Equipment, Supplies & Distribution

Jul 07, 2020 07:00 am ET
Livongo Announces Preliminary Second Quarter 2020 Revenue; Exceeds Previously Announced Guidance
Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary financial result for the second quarter of fiscal year 2020. Livongo now expects revenue for the second quarter of 2020 to be in the range of $86 million to $87 million, up from...
Jun 29, 2020 09:57 am ET
Telemedicine, Remote Workforces & Learning & Virtual Tradeshows: CEO’s of LVGO, NEXCF, AVYA, FVRR Discuss Tech Powering “Work From Home /Learn From Home” - at Scale
Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at Avaya Holdings Corp. (NYSE: AVYA), NexTech AR (OTC: NEXCF) (CSE: NTAR), Fiverr International Ltd. (NYSE:...
Jun 18, 2020 01:30 pm ET
Livongo Studies Leverage Proprietary Data and Remote Monitoring to Reveal Unique Diabetes Management Insights
Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of two studies that demonstrate how remote monitoring...
Jun 12, 2020 09:22 am ET
Capital Market Laboratories (CMLviz) One-on-One with Livongo Health CEO: Major acceleration in tele-health and remote patient monitoring together with its whole chronic condition platform yields a ‘ma
In an interview with Capital Market Laboratories (CMLviz), Chief Executive Office Officer of Livongo Health (NASDAQ:LVGO) had a clear message: The company has seen a major acceleration in tele-health and remote patient monitoring which ‘would’ve...
Jun 02, 2020 06:00 am ET
Livongo Announces Pricing of Upsized $475.0 Million Convertible Senior Notes Offering
Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the pricing of $475.0 million aggregate principal amount of...
Jun 01, 2020 06:46 am ET
Livongo Announces Proposed Offering of $400.0 Million of Convertible Senior Notes Due 2025
Livongo Health, Inc. (“Livongo”) (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it intends to offer $400.0 million aggregate principal...
May 26, 2020 09:00 am ET
Livongo to Present at Upcoming Investor Conferences
Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following...
May 13, 2020 09:31 am ET
Thinking about trading stocks or options in Livongo Health, JD.Com, CymaBay Therapeutics, GrubHub, or Ford?
NEW YORK, May 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for LVGO, JD, CBAY, GRUB, and F....
May 12, 2020 09:00 am ET
Livongo to Present at Upcoming Investor Conferences
Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following...
May 06, 2020 04:01 pm ET
Livongo Reports First Quarter 2020 Financial Results
Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its first quarter ended March 31, 2020. “Livongo is...
Apr 09, 2020 08:00 am ET
Livongo Partners with Prognos Health to Drive More Personalized Health Nudges™ with Clinical Laboratory Analytics at Scale
Livongo Health, Inc. (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has partnered with Prognos Health, an AI-driven platform company...
Apr 07, 2020 08:00 am ET
Livongo Announces Preliminary First Quarter 2020 Revenue; Exceeds Previously Announced Guidance
Livongo Health, Inc., (Nasdaq: LVGO) today announced a preliminary financial result for the first quarter of fiscal year 2020. Livongo now expects revenue for the first quarter of 2020 to be in the range of $65.5 million to $66.5 million, versus...
Mar 26, 2020 09:00 am ET
The Health Transformation Alliance and Welltok Select Livongo as First Marketplace Partner
DENVER, March 26, 2020 /PRNewswire/ -- As the number of health and wellbeing programs continues to grow, large employers are increasingly challenged to organize and manage these programs for their employees. To streamline the selection, contracting and implementation process, the Health Transformation Alliance (HTA) and Welltok, its consumer engagement platform of choice, are creating a curated marketplace of these programs on behalf of the over 50 HTA Member/Owners across the nation. Today, Livongo Health, Inc. (NASDAQ: LVGO), the leading Applied Health Signals company empowering people wit...
Mar 12, 2020 08:30 am ET
Livongo Expands Relationship with CVS Health, Now Part of Chronic Condition Management Platform within Point Solutions Service
Livongo (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it is available through the CVS Health Point Solutions Management service. Point...
Mar 02, 2020 04:01 pm ET
Livongo Reports Fourth Quarter and Full Year Financial Results
Livongo Health, Inc.  (NASDAQ: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its fourth quarter and full year ended December 31,...
Feb 18, 2020 09:00 am ET
Livongo to Present at Upcoming Investor Conferences
Livongo Health, Inc., (Nasdaq: LVGO), the leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that executives from the Company will be presenting at the following...
Jan 29, 2020 09:00 am ET
Livongo to Release Results for the Fourth Quarter of Fiscal Year 2019
Livongo Health, Inc., (Nasdaq: LVGO) today announced it will hold a conference call on Monday, March 2, 2020, after close of the U.S. stock market at 4:30 p.m. Eastern Time to discuss results for the fourth quarter and full year 2019. Financial...
Jan 21, 2020 12:45 pm ET
Livongo Provides New Diabetes Management Solution to New Jersey State and School Health Plan Members
Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that Livongo’s Applied Health Signals platform will be available to New Jersey State and...
Jan 13, 2020 09:00 am ET
Livongo and Dexcom Partner to Integrate Dexcom’s G6 Continuous Glucose Monitoring System into Livongo’s Applied Health Signals Platform
Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, has partnered with Dexcom, Inc. (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM), to offer...
Jan 09, 2020 09:00 am ET
Livongo Diabetes and Hypertension Solutions Now Available via Higi Smart Stations at Major Retailers
Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, and Higi, a consumer health engagement company with a nationwide network of 10,000 Smart Health Stations,...
Dec 16, 2019 09:00 am ET
Livongo to Present at J.P. Morgan 38th Annual Healthcare Conference
Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating in the J.P. Morgan 38th Annual Healthcare...
Dec 12, 2019 09:10 am ET
Livongo Earns Preferred Status on New Express Scripts Digital Health Formulary
Livongo (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it will be included on Express Scripts new, industry-first Digital Health Formulary,...
Dec 11, 2019 07:42 pm ET
Livongo Announces Pricing of Public Offering by Selling Stockholders
Livongo Health, Inc. (Nasdaq: LVGO) today announced the pricing of its underwritten public offering of 2,777,327 shares of its common stock by certain selling stockholders at a price of $27.00 per share. Such selling stockholders have also granted...
Dec 09, 2019 04:43 pm ET
Livongo Announces Launch of Proposed Public Offering by Selling Stockholders
Livongo Health, Inc. (Nasdaq: LVGO) today announced plans for the commencement of an underwritten public offering of 2,777,327 shares of common stock by certain selling stockholders. Such selling stockholders also intend to grant the underwriters a...
Nov 21, 2019 09:00 am ET
Livongo to Present at Piper Jaffray 31st Annual Healthcare Conference
Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating in the Piper Jaffray 31st Annual...
Nov 14, 2019 09:00 am ET
Livongo Study Demonstrates Sustained Blood Pressure Reduction for People Living with Both Diabetes and Hypertension Outside Traditional Care Settings
Livongo Health, Inc. (NASDAQ: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the findings of a study that demonstrated people with both diabetes and high...
Nov 06, 2019 04:01 pm ET
Livongo Reports Third Quarter Financial Results
Livongo Health, Inc.  (NASDAQ: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its third quarter ended September 30, 2019. “We...
Oct 31, 2019 09:00 am ET
Livongo Announces Updated Presentation Time at Credit Suisse 28th Annual Healthcare Conference
Livongo Health, Inc., (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives,  today announced a change to its presentation time at the Credit Suisse 28th Annual...
Oct 28, 2019 09:00 am ET
Livongo Integrates Access to Telehealth in Support of People Living with Chronic Conditions
Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced at the HLTH 2019 Conference being held in Las Vegas, Nevada, that it has...
Oct 17, 2019 09:00 am ET
Livongo Expands Partnership with Blue Cross and Blue Shield of Kansas City
Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced that it has expanded its partnership with Blue Cross and Blue Shield of...
Oct 15, 2019 09:07 am ET
Livongo and VSP Vision Care Partner to Reduce Gaps in Eye Care for People Living with Diabetes
Livongo Health, Inc., a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced a partnership with VSP® Vision Care to expand outreach efforts to Members with diabetes....
Oct 14, 2019 04:01 pm ET
Livongo to Release Results for the Third Quarter of Fiscal Year 2019
Livongo Health, Inc., (Nasdaq: LVGO) today announced it will hold a conference call on Wednesday, November 6, 2019, after close of U.S. stock market at 4:30 p.m. Eastern Time to discuss results for third quarter ended September 30, 2019. Financial...
Oct 14, 2019 09:00 am ET
Livongo to Present at Credit Suisse 28th Annual Healthcare Conference
Livongo Health, Inc., (Nasdaq: LVGO) today announced the Company will be participating in the Credit Suisse 28th Annual Healthcare Conference in Scottsdale, AZ. Management is scheduled to present on Wednesday, November 13, 2019 at 10:55 a.m....
Oct 07, 2019 07:00 am ET
Livongo Awarded Diabetes Contract for Eligible Population for Approximately 5.3 Million Beneficiaries Through the Federal Employees Health Benefits Program
Livongo Health, Inc (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced it was awarded a contract to provide the Livongo for Diabetes solution to...
Sep 05, 2019 05:30 am ET
Livongo Reports Second Quarter Financial Results
Livongo Health, Inc. (NASDAQ: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter ended June 30, 2019. “Our...
Aug 27, 2019 04:01 pm ET
Livongo to Present at Morgan Stanley 17th Annual Healthcare Conference
Livongo Health, Inc. (Nasdaq: LVGO), a leading Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced the Company will be participating in the Morgan Stanley 17th Annual...
Aug 20, 2019 09:00 am ET
Livongo Founder and Executive Chairman Glen Tullman Honored with Robert F. Kennedy Human Rights Ripple of Hope Award
Today, Livongo announced that Founder and Executive Chairman Glen Tullman will be honored with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system....
Aug 07, 2019 09:00 am ET
Livongo to Release Results for the Second Quarter of Fiscal Year 2019
Livongo Health, Inc. (Nasdaq: LVGO) today announced it will hold a conference call on Thursday, September 5, 2019 at 8:00 a.m. Eastern Time to discuss the Company’s financial results and other information for the three months ended June 30, 2019....
Jul 29, 2019 04:01 pm ET
Livongo Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Livongo Health, Inc., (Nasdaq: LVGO) today announced the closing of its initial public offering of 14,590,050 shares of its common stock at a price of $28.00 per share, which includes the full exercise of the underwriters’ option to purchase...
Jul 24, 2019 08:40 pm ET
Livongo Announces Pricing of Initial Public Offering
Livongo Health, Inc. (Livongo) today announced the pricing of its initial public offering of 12,687,000 shares of its common stock at a price of $28.00 per share for total gross proceeds of approximately $355.2 million. In addition, Livongo has...